previous efforts to treat babies with the same protein shortly after birth had failed, schneider said.
.
.". plemmons added, "particularly in a time when mental health resources for children appear to be static, and woefully scarce across the u.s".
.: "targeted cgrp small molecule antagonists for acute migraine therapy."
.
.
sponsored by an innovative medicines canada company
.
